Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples